AgeX Therapeutics Licensee ImStem Biotechnology Announces FDA has Lifted the Hold and Cleared the Investigational New Drug Application for IMS001 for the Treatment of Multiple Sclerosis

Stock Information for Credit Suisse Agriculture Index

Loading

Please wait while we load your information from QuoteMedia.